Back to today’s briefing

Story perspectives

FDA Approves HIV Treatment, Transforming LGBTQ+ Healthcare Access

6/27/2025

30 6

Summary

Story summary

Over the past ten years, LGBTQ+ healthcare has made remarkable strides, especially in gender-affirming care, thanks to new guidelines and better insurance coverage. The recent FDA approval of long-acting HIV prevention treatments, such as lenacapavir, promises to boost access and adherence, tackling health disparities for transgender individuals and the wider LGBTQ+ community in the U.S.

1 of 1

Story summary

Over the past ten years, LGBTQ+ healthcare has made remarkable strides, especially in gender-affirming care, thanks to new guidelines and better insurance coverage. The recent FDA approval of long-acting HIV prevention treatments, such as lenacapavir, promises to boost access and adherence, tackling health disparities for transgender individuals and the wider LGBTQ+ community in the U.S.